Pfizer, Flynn Still Face Fines Over Epilepsy Drug Sale To NHS
Britain's competition tribunal issued a ruling Wednesday imposing £69 million ($87.2 million) in fines on Pfizer Ltd. and Flynn Pharma Ltd. for claims they overcharged for an epilepsy drug, after setting...To view the full article, register now.
Already a subscriber? Click here to view full article